Benitec Biopharma (ASX:BLT)
Share Price and News


Company Profile:

The Sydney-based Benitec Biopharma (ASX: BLT), established in 1995, is a clinical-stage biotechnology company which develops novel genetic medicines in laboratories in Hayward, California (USA), with collaborators and licensees around the world. It has a patent over DNA-directed RNA interference or ddRNAi platform, which combines RNA interference, or RNAi, and gene therapy to develop medicines that assist in silencing of disease-causing genes following a single administration for a sustained period of time.



Code : ASX:BLT Healthcare Company